Home/Filings/4/0001857256-25-000004
4//SEC Filing

Peterson Caryn 4

Accession 0001857256-25-000004

CIK 0001728117other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:11 PM ET

Size

4.9 KB

Accession

0001857256-25-000004

Insider Transaction Report

Form 4
Period: 2025-10-01
Peterson Caryn
EVP, Regulatory Affairs
Transactions
  • Award

    Common Stock

    2025-10-01+125,000174,833 total
Footnotes (1)
  • [F1]Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001857256

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:11 PM ET
Size
4.9 KB